Skip to main content
Veterinary Medicines

Lambivac, vet, stungulyf, dreifa, dreifa handa sauðfé

Authorised
  • Clostridium tetani, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type B, beta toxoid

Product identification

Medicine name:
Lambivac, vet, stungulyf, dreifa, dreifa handa sauðfé
Active substance:
  • Clostridium tetani, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type B, beta toxoid
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB01
Authorisation status:
  • Valid
Authorised in:
  • Iceland
Available in:
  • Iceland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Icelandic Medicines Agency
Authorisation number:
  • 940136
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Icelandic (PDF)
Published on: 16/02/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Icelandic (PDF)
Published on: 13/09/2024